SAREPTA THERAPEUTICS, INC. Other Noncash Income (Expense)
SAREPTA THERAPEUTICS, INC. (SRPT) reported Other Noncash Income (Expense) of $1.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-08-05
- SAREPTA THERAPEUTICS, INC. other noncash income (expense) for the quarter ending 2026-06-30 was $10.00K.
- SAREPTA THERAPEUTICS, INC. other noncash income (expense) for the quarter ending 2026-03-31 was $1.29M.
- SAREPTA THERAPEUTICS, INC. other noncash income (expense) for the quarter ending 2025-12-31 was -$2.62M, a 176.07% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. other noncash income (expense) for the quarter ending 2025-09-30 was -$3.74M.
- SAREPTA THERAPEUTICS, INC. other noncash income (expense) for fiscal 2025 was -$7.05M.
- SAREPTA THERAPEUTICS, INC. other noncash income (expense) for fiscal 2024 was -$2.13M, a 283.15% decline from fiscal 2023.
- SAREPTA THERAPEUTICS, INC. other noncash income (expense) for fiscal 2023 was $1.16M.
- SAREPTA THERAPEUTICS, INC. other noncash income (expense) for fiscal 2022 was -$11.78M.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 3 month as first filed | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 6 month as first filed | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 9 month as first filed | Other Noncash Income (Expense) 12 month | Other Noncash Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.30M 10-Q · filed 2026-08-05 | -$1.32M derived: sum of 3 quarters · filed 2026-08-05 | -$5.06M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $1.29M 10-Q · filed 2026-05-06 | -$1.33M derived: sum of 2 quarters · filed 2026-05-06 | -$5.07M derived: sum of 3 quarters · filed 2026-05-06 | -$5.33M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | -$2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$6.35M derived: sum of 2 quarters · filed 2026-03-02 | -$6.62M derived: sum of 3 quarters · filed 2026-08-05 | -$7.05M 10-K · filed 2026-03-02 | ||||
| 2025-09-30 | -$3.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$4.00M derived: sum of 2 quarters · filed 2026-08-05 | -$4.44M 10-Q · filed 2025-11-06 | -$1.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | -$263.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$701.00K 10-Q · filed 2026-08-05 | -$3.30M 10-Q · filed 2025-08-06 | $2.74M derived: sum of 3 quarters · filed 2026-08-05 | -$318.00K derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-03-31 | -$438.00K 10-Q · filed 2026-05-06 | -$1.69M 10-Q · filed 2025-05-06 | $3.00M derived: sum of 2 quarters · filed 2026-05-06 | -$55.00K derived: sum of 3 quarters · filed 2026-05-06 | -$1.31M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | $3.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $383.00K derived: sum of 2 quarters · filed 2026-03-02 | -$870.00K derived: sum of 3 quarters · filed 2026-03-02 | -$2.13M 10-K · filed 2026-03-02 | ||||
| 2024-09-30 | -$3.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$4.31M derived: sum of 2 quarters · filed 2025-11-06 | -$5.57M 10-Q · filed 2025-11-06 | -$1.82M 10-Q · filed 2024-11-06 | -$4.08M derived: sum of 4 quarters · filed 2026-03-02 | |||
| 2024-06-30 | -$1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$2.51M 10-Q · filed 2025-08-06 | $1.07M 10-Q · filed 2024-08-07 | -$1.03M derived: sum of 3 quarters · filed 2026-03-02 | -$705.00K derived: sum of 4 quarters · filed 2026-03-02 | |||
| 2024-03-31 | -$1.26M 10-Q · filed 2025-05-06 | -$329.00K 10-Q · filed 2024-05-01 | $227.00K derived: sum of 2 quarters · filed 2026-03-02 | $548.00K derived: sum of 3 quarters · filed 2026-03-02 | $1.87M derived: sum of 4 quarters · filed 2026-03-02 | |||
| 2023-12-31 | $1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $1.81M derived: sum of 2 quarters · filed 2026-03-02 | $3.13M derived: sum of 3 quarters · filed 2026-03-02 | $1.16M 10-K · filed 2026-03-02 | -$37.00K 10-K · filed 2024-02-28 | |||
| 2023-09-30 | $321.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $1.64M derived: sum of 2 quarters · filed 2024-11-06 | -$324.00K 10-Q · filed 2024-11-06 | -$1.52M 10-Q · filed 2023-11-01 | -$12.69M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2023-06-30 | $1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$645.00K 10-Q · filed 2024-08-07 | $477.00K 10-Q · filed 2023-08-02 | -$13.01M derived: sum of 3 quarters · filed 2025-02-28 | -$11.96M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2023-03-31 | -$1.96M 10-Q · filed 2024-05-01 | -$14.33M derived: sum of 2 quarters · filed 2025-02-28 | -$13.27M derived: sum of 3 quarters · filed 2025-02-28 | -$9.90M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | -$12.36M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$11.31M derived: sum of 2 quarters · filed 2025-02-28 | -$7.93M derived: sum of 3 quarters · filed 2025-02-28 | -$11.78M 10-K · filed 2025-02-28 | $9.64M 10-K · filed 2023-02-28 | |||
| 2022-09-30 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $4.43M derived: sum of 2 quarters · filed 2023-11-01 | $584.00K 10-Q · filed 2023-11-01 | $3.86M 10-Q · filed 2022-11-02 | $3.58M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2022-06-30 | $3.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$468.00K 10-Q · filed 2023-08-02 | $991.00K 10-Q · filed 2022-08-02 | $2.53M derived: sum of 3 quarters · filed 2024-02-28 | $2.35M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2022-03-31 | -$3.85M 10-Q · filed 2023-05-02 | -$1.84M 10-Q · filed 2022-05-04 | -$851.00K derived: sum of 2 quarters · filed 2024-02-28 | -$1.02M derived: sum of 3 quarters · filed 2024-02-28 | -$1.68M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2021-12-31 | $2.99M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $2.82M derived: sum of 2 quarters · filed 2024-02-28 | $2.17M derived: sum of 3 quarters · filed 2024-02-28 | -$522.00K 10-K · filed 2024-02-28 | -$7.62M 10-K · filed 2022-03-01 | |||
| 2021-09-30 | -$173.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$824.00K derived: sum of 2 quarters · filed 2022-11-02 | -$3.52M 10-Q · filed 2022-11-02 | -$3.96M 10-Q · filed 2021-11-03 | -$2.81M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-06-30 | -$651.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$3.34M 10-Q · filed 2022-08-02 | -$3.79M 10-Q · filed 2021-08-04 | -$2.63M derived: sum of 3 quarters · filed 2023-02-28 | -$1.40M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-03-31 | -$2.69M 10-Q · filed 2022-05-04 | -$2.77M 10-Q · filed 2021-05-05 | -$1.98M derived: sum of 2 quarters · filed 2023-02-28 | -$751.00K derived: sum of 3 quarters · filed 2023-02-28 | -$1.33M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2020-12-31 | $710.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $1.94M derived: sum of 2 quarters · filed 2023-02-28 | $1.36M derived: sum of 3 quarters · filed 2023-02-28 | $2.74M 10-K · filed 2023-02-28 | $470.00K 10-K · filed 2021-03-01 | |||
| 2020-09-30 | $1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $650.00K derived: sum of 2 quarters · filed 2021-11-03 | $2.03M 10-Q · filed 2021-11-03 | -$75.00K 10-Q · filed 2020-11-05 | $10.68M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-06-30 | -$581.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $800.00K 10-Q · filed 2021-08-04 | $9.45M derived: sum of 3 quarters · filed 2022-03-01 | $9.45M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | $1.38M 10-Q · filed 2021-05-05 | $10.03M derived: sum of 2 quarters · filed 2022-03-01 | $10.03M derived: sum of 3 quarters · filed 2022-03-01 | $9.22M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | $8.65M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $8.65M derived: sum of 2 quarters · filed 2022-03-01 | $7.84M derived: sum of 3 quarters · filed 2022-03-01 | $7.75M 10-K · filed 2022-03-01 | -$690.00K 10-K · filed 2021-03-01 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$804.00K derived: sum of 2 quarters · filed 2020-11-05 | -$892.00K 10-Q · filed 2020-11-05 | |||||
| 2019-06-30 | -$804.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$892.00K 10-Q · filed 2020-08-05 | ||||||
| 2019-03-31 | -$88.00K 10-Q · filed 2020-05-06 | |||||||
| 2018-12-31 | -$3.94M 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |